-- 法国兴业银行表示,对欧元区政府债券资金流动情况的每周分析显示,截至上周五当周,投资者净买入德国国债(Bund)、意大利国债(BTP)和西班牙国债(SPGB),净卖出法国国债(OAT)。 ——德国国债本周出现净买入,延续了此前七周的趋势,主要由国内和国外投资者推动。国内投资者连续11周净买入,买盘主要集中在2-5年期和20年以上期限的债券,其中资产管理公司和银行最为活跃。国外投资者也连续第八周净买入,主要买入期限为5-10年,主要由银行和对冲基金主导。 ——法国国债出现净卖出,扭转了此前七周的趋势,主要由国外投资者推动。国内投资者连续第12周净买入,交易活动主要集中在10-20年期和20年以上期限的债券,主要由资产管理公司和保险公司主导。与此同时,非国内投资者在连续七周净买入后转为净卖出,主要由银行和保险公司推动,交易活动主要集中在10-20年期和20年以上期限的债券。 ——意大利国债(BTP)出现净买入,扭转了前一周的抛售趋势,国内和非国内投资者均推动了这一趋势。国内投资者继续净买入,延续了五周的买入势头,交易活动主要集中在5-10年期债券,主要由银行主导。非国内投资者也转为净买入,扭转了上周的抛售趋势,主要由保险公司和对冲基金推动,主要集中在20年以上期限的债券。 ——法国国债(SPGB)出现净买入,扭转了前四周的抛售趋势,国内和非国内投资者均推动了这一趋势。国内投资者本周转为净买入,延续了此前五周的买入趋势,交易活动主要集中在10-20年期和20年以上期限的债券,主要由银行和保险公司推动。境外投资者在上周净卖出后,本周也转为净买入,交易活动主要集中在20年以上期限和10-20年期限的债券,主要由保险公司和银行推动。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.